Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
phase 2b
Articles
1
From
2026-07-22 12:30:00+00
To
2026-07-22 12:30:00+00
Range
2026-07-21 19:13:41.275433+00 →
2026-07-22 19:13:41.275433+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| 1 billion | MONEY | 1 | 📊 🔍 🧲 |
| agency | ORG | 1 | 📊 🔍 🧲 |
| alon bennoon | PERSON | 1 | 📊 🔍 🧲 |
| als | ORG | 1 | 📊 🔍 🧲 |
| als news | ORG | 1 | 📊 🔍 🧲 |
| cambridge | GPE | 1 | 📊 🔍 🧲 |
| canada | GPE | 1 | 📊 🔍 🧲 |
| canadian | NORP | 1 | 📊 🔍 🧲 |
| company | ORG | 1 | 📊 🔍 🧲 |
| eu | ORG | 1 | 📊 🔍 🧲 |
| every year | DATE | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| health canada | ORG | 1 | 📊 🔍 🧲 |
| health canadas | ORG | 1 | 📊 🔍 🧲 |
| GPE | 1 | 📊 🔍 🧲 | |
| mass | GPE | 1 | 📊 🔍 🧲 |
| nasdaq | ORG | 1 | 📊 🔍 🧲 |
| nds | ORG | 1 | 📊 🔍 🧲 |
| neurosense | ORG | 1 | 📊 🔍 🧲 |
| neurosense advances | ORG | 1 | 📊 🔍 🧲 |
| neurosense jul 22 2026 | ORG | 1 | 📊 🔍 🧲 |
| neurosense therapeutics | ORG | 1 | 📊 🔍 🧲 |
| neurosense therapeutics ltd | ORG | 1 | 📊 🔍 🧲 |
| paradigm | ORG | 1 | 📊 🔍 🧲 |
| phase 2b | LAW | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-22 12:30:00+00 | Health |
|
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS | Analyze | NeuroSense | 😐 neutral | 0.0959 |